CVS HEALTH CORPORATION Policyholder Benefits and Claims Incurred, Direct
CVS HEALTH CORPORATION (CVS) reported Policyholder Benefits and Claims Incurred, Direct of $126.26 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PolicyholderBenefitsAndClaimsIncurredGross · last filed 2026-02-10
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, direct for fiscal 2025 was $126.26B, a 8.87% increase from fiscal 2024.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, direct for fiscal 2024 was $115.97B, a 33.71% increase from fiscal 2023.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, direct for fiscal 2023 was $86.74B, a 21.55% increase from fiscal 2022.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, direct for fiscal 2022 was $71.36B, a 10.91% increase from fiscal 2021.
| Period end | Policyholder Benefits and Claims Incurred, Direct 12 month | Policyholder Benefits and Claims Incurred, Direct 12 month as first filed |
|---|---|---|
| 2025-12-31 | $126.26B 10-K · filed 2026-02-10 | |
| 2024-12-31 | $115.97B 10-K · filed 2026-02-10 | |
| 2023-12-31 | $86.74B 10-K · filed 2026-02-10 | |
| 2022-12-31 | $71.36B 10-K · filed 2025-02-12 | $71.57B 10-K · filed 2023-02-08 |
| 2021-12-31 | $64.34B 10-K · filed 2024-02-07 | $64.41B 10-K · filed 2022-02-09 |
| 2020-12-31 | $56.08B 8-K · filed 2023-05-25 | |
| 2019-12-31 | $52.59B 10-K · filed 2022-02-09 | |
| 2018-12-31 | $6.77B 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |